Microarray-based Non-Invasive Prenatal Testing - Global and China Top Players Market Share and Ranking 2025- YH Research

Home > Reports >Service & Software > Microarray-based Non-Invasive Prenatal Testing - Global and China Top Players Market Share and Ranking 2025

Microarray-based Non-Invasive Prenatal Testing - Global and China Top Players Market Share and Ranking 2025

Publication Date: 2025-05-14
Report Id: 2133274
Industry: Service & Software
Report Page: 107
Chart: 101

PDF Download

Publication Date: 2025-05-14
Report Id: 2133274
Industry: Service & Software
Report Page: 107
Chart: 101

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Microarray-based Non-Invasive Prenatal Testing Definition
1.2 Global Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast
1.3 China Microarray-based Non-Invasive Prenatal Testing Market Size and Forecast
1.4 Share of China Microarray-based Non-Invasive Prenatal Testing Market with Respect to the Global Market
1.5 Microarray-based Non-Invasive Prenatal Testing Market Size: China VS Global Growth Rate, 2020-2031
1.6 Microarray-based Non-Invasive Prenatal Testing Market Dynamics
1.6.1 Microarray-based Non-Invasive Prenatal Testing Market Drivers
1.6.2 Microarray-based Non-Invasive Prenatal Testing Market Restraints
1.6.3 Microarray-based Non-Invasive Prenatal Testing Industry Trends
1.6.4 Microarray-based Non-Invasive Prenatal Testing Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Microarray-based Non-Invasive Prenatal Testing, Global Market Share by Company, 2020-2025
2.2 Global Microarray-based Non-Invasive Prenatal Testing Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Microarray-based Non-Invasive Prenatal Testing Concentration Ratio
2.4 Global Microarray-based Non-Invasive Prenatal Testing Mergers & Acquisitions, Expansion Plans
2.5 Global Microarray-based Non-Invasive Prenatal Testing Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Microarray-based Non-Invasive Prenatal Testing, China Market Share by Company, 2020-2025
3.2 China Microarray-based Non-Invasive Prenatal Testing Microarray-based Non-Invasive Prenatal Testing Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Microarray-based Non-Invasive Prenatal Testing Industry Chain
4.2 Microarray-based Non-Invasive Prenatal Testing Upstream Analysis
4.2.1 Microarray-based Non-Invasive Prenatal Testing Core Raw Materials
4.2.2 Main Manufacturers of Microarray-based Non-Invasive Prenatal Testing Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Microarray-based Non-Invasive Prenatal Testing Production Mode
4.6 Microarray-based Non-Invasive Prenatal Testing Procurement Model
4.7 Microarray-based Non-Invasive Prenatal Testing Industry Sales Model and Sales Channels
4.7.1 Microarray-based Non-Invasive Prenatal Testing Sales Model
4.7.2 Microarray-based Non-Invasive Prenatal Testing Typical Distributors

5 Sights by Type
5.1 Microarray-based Non-Invasive Prenatal Testing Classification
5.1.1 Trisomy Detection
5.1.2 Microdeletion Syndromes
5.1.3 Other
5.2 by Type, Global Microarray-based Non-Invasive Prenatal Testing Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Microarray-based Non-Invasive Prenatal Testing Consumption Value, 2020-2031

6 Sights by Application
6.1 Microarray-based Non-Invasive Prenatal Testing Segment by Application
6.1.1 Hospitals & Clinics
6.1.2 Independent Laboratories
6.2 by Application, Global Microarray-based Non-Invasive Prenatal Testing Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Microarray-based Non-Invasive Prenatal Testing Consumption Value, 2020-2031

7 Sales Sights by Region
7.1 By Region, Global Microarray-based Non-Invasive Prenatal Testing Consumption Value, 2020 VS 2024 VS 2031
7.2 By Region, Global Microarray-based Non-Invasive Prenatal Testing Consumption Value, 2020-2031
7.3 North America
7.3.1 North America Microarray-based Non-Invasive Prenatal Testing Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Microarray-based Non-Invasive Prenatal Testing Market Size Market Share
7.4 Europe
7.4.1 Europe Microarray-based Non-Invasive Prenatal Testing Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Microarray-based Non-Invasive Prenatal Testing Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Microarray-based Non-Invasive Prenatal Testing Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Microarray-based Non-Invasive Prenatal Testing Market Size Market Share
7.6 South America
7.6.1 South AmericaMicroarray-based Non-Invasive Prenatal Testing Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Microarray-based Non-Invasive Prenatal Testing Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global Microarray-based Non-Invasive Prenatal Testing Market Size & CAGR, 2020 VS 2024 VS 2031
8.2 By Country, Global Microarray-based Non-Invasive Prenatal Testing Consumption Value, 2020-2031
8.3 United States
8.3.1 United States Microarray-based Non-Invasive Prenatal Testing Market Size, 2020-2031
8.3.2 by Type, United States Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.3.3 by Application, United States Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Microarray-based Non-Invasive Prenatal Testing Market Size, 2020-2031
8.4.2 by Type, Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.4.3 by Application, Europe Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.5 China
8.5.1 China Microarray-based Non-Invasive Prenatal Testing Market Size, 2020-2031
8.5.2 by Type, China Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.5.3 by Application, China Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Microarray-based Non-Invasive Prenatal Testing Market Size, 2020-2031
8.6.2 by Type, Japan Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.6.3 by Application, Japan Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Microarray-based Non-Invasive Prenatal Testing Market Size, 2020-2031
8.7.2 by Type, South Korea Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.7.3 by Application, South Korea Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Microarray-based Non-Invasive Prenatal Testing Market Size, 2020-2031
8.8.2 by Type, Southeast Asia Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.8.3 by Application, Southeast Asia Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.9 India
8.9.1 India Microarray-based Non-Invasive Prenatal Testing Market Size, 2020-2031
8.9.2 by Type, India Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.9.3 by Application, India Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Market Size, 2020-2031
8.10.2 by Type, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031
8.10.3 by Application, Middle East & Africa Microarray-based Non-Invasive Prenatal Testing Consumption Value Market Share, 2024 VS 2031

9 Company Profile
9.1 Agilent Technologies
9.1.1 Agilent Technologies Company Information, Head Office, Market Area, and Industry Position
9.1.2 Agilent Technologies Company Profile and Main Business
9.1.3 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Models, Specifications, and Application
9.1.4 Agilent Technologies Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin, 2020-2025
9.1.5 Agilent Technologies Recent Developments
9.2 Ariosa Diagnostics (Roche)
9.2.1 Ariosa Diagnostics (Roche) Company Information, Head Office, Market Area, and Industry Position
9.2.2 Ariosa Diagnostics (Roche) Company Profile and Main Business
9.2.3 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Models, Specifications, and Application
9.2.4 Ariosa Diagnostics (Roche) Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin, 2020-2025
9.2.5 Ariosa Diagnostics (Roche) Recent Developments
9.3 BGI Group
9.3.1 BGI Group Company Information, Head Office, Market Area, and Industry Position
9.3.2 BGI Group Company Profile and Main Business
9.3.3 BGI Group Microarray-based Non-Invasive Prenatal Testing Models, Specifications, and Application
9.3.4 BGI Group Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin, 2020-2025
9.3.5 BGI Group Recent Developments
9.4 Eurofins LifeCodexx GmbH
9.4.1 Eurofins LifeCodexx GmbH Company Information, Head Office, Market Area, and Industry Position
9.4.2 Eurofins LifeCodexx GmbH Company Profile and Main Business
9.4.3 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Models, Specifications, and Application
9.4.4 Eurofins LifeCodexx GmbH Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin, 2020-2025
9.4.5 Eurofins LifeCodexx GmbH Recent Developments
9.5 Illumina
9.5.1 Illumina Company Information, Head Office, Market Area, and Industry Position
9.5.2 Illumina Company Profile and Main Business
9.5.3 Illumina Microarray-based Non-Invasive Prenatal Testing Models, Specifications, and Application
9.5.4 Illumina Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin, 2020-2025
9.5.5 Illumina Recent Developments
9.6 Laboratory Corporation of America
9.6.1 Laboratory Corporation of America Company Information, Head Office, Market Area, and Industry Position
9.6.2 Laboratory Corporation of America Company Profile and Main Business
9.6.3 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Models, Specifications, and Application
9.6.4 Laboratory Corporation of America Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin, 2020-2025
9.6.5 Laboratory Corporation of America Recent Developments
9.7 Myriad Genetics
9.7.1 Myriad Genetics Company Information, Head Office, Market Area, and Industry Position
9.7.2 Myriad Genetics Company Profile and Main Business
9.7.3 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Models, Specifications, and Application
9.7.4 Myriad Genetics Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin, 2020-2025
9.7.5 Myriad Genetics Recent Developments
9.8 Natera
9.8.1 Natera Company Information, Head Office, Market Area, and Industry Position
9.8.2 Natera Company Profile and Main Business
9.8.3 Natera Microarray-based Non-Invasive Prenatal Testing Models, Specifications, and Application
9.8.4 Natera Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin, 2020-2025
9.8.5 Natera Recent Developments
9.9 PerkinElmer Inc
9.9.1 PerkinElmer Inc Company Information, Head Office, Market Area, and Industry Position
9.9.2 PerkinElmer Inc Company Profile and Main Business
9.9.3 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Models, Specifications, and Application
9.9.4 PerkinElmer Inc Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin, 2020-2025
9.9.5 PerkinElmer Inc Recent Developments
9.10 Quest Diagnostics
9.10.1 Quest Diagnostics Company Information, Head Office, Market Area, and Industry Position
9.10.2 Quest Diagnostics Company Profile and Main Business
9.10.3 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Models, Specifications, and Application
9.10.4 Quest Diagnostics Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin, 2020-2025
9.10.5 Quest Diagnostics Recent Developments
9.11 Sequenom
9.11.1 Sequenom Company Information, Head Office, Market Area, and Industry Position
9.11.2 Sequenom Company Profile and Main Business
9.11.3 Sequenom Microarray-based Non-Invasive Prenatal Testing Models, Specifications, and Application
9.11.4 Sequenom Microarray-based Non-Invasive Prenatal Testing Revenue and Gross Margin, 2020-2025
9.11.5 Sequenom Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Microarray-based Non-Invasive Prenatal Testing should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of %for the period of 2025-2031.

For expectant mothers, microarray-based non-invasive prenatal testing (NIPT) provides a secure and educational screening choice. To determine the likelihood of chromosomal abnormalities in the foetus, it examines cell-free foetal DNA that is circulating in the mother's blood. In contrast to conventional techniques that may result in miscarriage, NIPT is a blood test. With a detection rate for Down syndrome that is above 99%, this extremely reliable test yields findings in less than a week. In comparison to earlier techniques, it can even test for a wider spectrum of disorders. However, NIPT is only a screening tool and not a conclusive diagnosis. It could require more testing to be confirmed. It might not be appropriate for all pregnancies, and the cost and insurance coverage can differ.

By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Microarray-based Non-Invasive Prenatal Testing market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031. The United States Microarray-based Non-Invasive Prenatal Testing market should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of % for the period of 2025-2031.

By segment, Hospitals & Clinics grew percent to account for percent of the total market sales, and Independent Laboratories grew percent.

This report studies and analyses global Microarray-based Non-Invasive Prenatal Testing status and future trends, to help determine the Microarray-based Non-Invasive Prenatal Testing market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Microarray-based Non-Invasive Prenatal Testing, and provides market size (US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Microarray-based Non-Invasive Prenatal Testing market size, history data 2020-2025, and forecast data 2026 -2031, (US$ million)
(2) Global Microarray-based Non-Invasive Prenatal Testing by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(3) China Microarray-based Non-Invasive Prenatal Testing by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(4) Global Microarray-based Non-Invasive Prenatal Testing key consuming regions, consumption value and demand structure
(5) Microarray-based Non-Invasive Prenatal Testing industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Agilent Technologies
    Ariosa Diagnostics (Roche)
    BGI Group
    Eurofins LifeCodexx GmbH
    Illumina
    Laboratory Corporation of America
    Myriad Genetics
    Natera
    PerkinElmer Inc
    Quest Diagnostics
    Sequenom

Market segment by Type, covers
    Trisomy Detection
    Microdeletion Syndromes
    Other

Market segment by Application, can be divided into
    Hospitals & Clinics
    Independent Laboratories

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Microarray-based Non-Invasive Prenatal Testing product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Microarray-based Non-Invasive Prenatal Testing market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 3: China Microarray-based Non-Invasive Prenatal Testing market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 4: Microarray-based Non-Invasive Prenatal Testing industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2020-2031
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2020-2031
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions